National Natural Science Foundations of China(Grant No.81960863);the Education Department of Yunnan Province(Grant No.2023Y0463 and 2024Y380);Yunnan Clinical Research Center for rheumatism in Traditional Chinese Medicine(Grant No.202405AJ310004).
Hyperuricemia(HUA)is a metabolic disorder characterized by elevated levels of uric acid in the blood,resulting from either increased production or decreased excretion of uric acid.This condition has reached epidemic p...
2023 Nantong Jianghai Talents Project,the Nantong Social Livelihood Science and Technology Plan for 2023;the 2022 New Drugs and Platform Enhancement Project of the Yangtze Delta Drug Advanced Research Institute.Additionally,support was p rovided by the Zhenjiang Science and Technology Project(Grant No.SH2020048);the China Postdoctoral Science Foundation(Grant No.2020M681532);the Jiangsu Planned Projects for Postdoctoral Research Funds(Grant No.2020Z209);the Natural Science Research Projects of Universities in Jiangsu Province(Grant No.20KJD350001).
The aim of this study was to develop a novel pharmaceutical excipient:an anion exchange resin.Initially,polystyrenedivinylbenzene(PS-DVB)microspheres were synthesized via suspension polymerization.Subsequently,these m...
Shanxi Province Traditional Chinese Medicine Administration Research Project(Grant No.2022ZYYC094);Science and technology innovation project of universities in Shanxi Province(Grant No.2022L342);Shanxi Leader Team of Medical Science&Technology Innovations(Grant No.2020TD02);Discipline Construction Project of Chinese Medicine Chemistry(Grant No.2024XKJS-25).
The aim of this study is to observe the therapeutic effect of Inonotus Obliquus Polysaccharide(IOP)on chronic nonbacterial prostatitis(CNP)and its effect on the helper T cells(Th17)and regulatory T cells(Treg)immune i...
Foundation items:Wuhan Health Research Fund(Grant No.WZ21A06);National Natural Science Foundation of China(Grant No.81903815)。
This study aimed to assess the therapeutic potential of Anemarrhenae Rhizoma(AR)in osteoporotic rats and to elucidate the metabolic pathways involved in AR’s role in alleviating osteoporosis(OP).OP was induced in rat...
Yunnan Provincial Excellent Clinical Talents Training Project(the First Batch)(Yunnan Financial Society(2024)No.103).
This research aimed to identify and validate ferroptosis-related signature genes associated with psoriasis through a comprehensive bioinformatics approach,while also predicting potential traditional Chinese medicines(...
National Natural Science Foundation of China(Grant No.81573969).
The present study aimed to analyze the potential mechanism of action of Chaihu-Astragalus in treating alcoholic liver fibrosis using network pharmacology and molecular docking techniques.We initially screened the acti...
China National Key Research and Development Program(Grant No.2020YFC2009000 and 2020YFC2009001);National High Level Hospital Clinical Research Funding(Grant No.BJ-2023-200);the project funding from the Drug Evaluation Center of the National Medical Products Administration(Grant No.CDRW20214001).
The aim of this study was to provide insights into the current status and primary methodologies employed by marketing authorization holders(MAHs)for signal detection.These insights are intended to offer valuable refer...
2024年11月27日,北京大学药学院天然药物及仿生药物全国重点实验室徐正仁团队在学术期刊Angew.Chem.Int.Ed.发表了题为“Chemoenzymatic Synthesis of the Cyclopiane Family of Diterpenoid Natural Products”(Cyclopiane家族二萜天...
2024年12月5日,北京大学药学院天然药物及仿生药物全国重点实验室汪贻广教授团队在国际知名学术期刊Journal of the American Chemical Society上发表了题为“Lysosome-Mitochondria Cascade Targeting Nanoparticle Drives Robust Pyro...
2024年12月20日,北京大学药学院天然药物及仿生药物全国重点室李鲜婵团队在Journal of the American Chemical Society杂志刊登了题为“Single-Vesicle Electrochemistry in Fresh Brain Slices Enables In-situ Quantification of Vesi...